What is the recommended dosage and usage of Pepto Bismol (bismuth subsalicylate) for treating gastrointestinal symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage and Usage of Pepto Bismol (Bismuth Subsalicylate)

For adults and children 12 years and over, the recommended dosage of Pepto Bismol (bismuth subsalicylate) is 2 chewable tablets every 30 minutes or 4 chewable tablets every hour as needed for diarrhea, not exceeding 8 doses (16 tablets) in 24 hours. 1

Dosage Guidelines for Different Gastrointestinal Symptoms

For Diarrhea:

  • Adults and children 12 years and over: 2 chewable tablets every 30 minutes or 4 chewable tablets every hour as needed 1
  • Continue use until diarrhea stops but not more than 2 days 1
  • Drink plenty of clear fluids to help prevent dehydration caused by diarrhea 1

For Upset Stomach, Heartburn, Indigestion, Nausea:

  • Adults and children 12 years and over: 2 chewable tablets every 30 minutes to 1 hour as needed 1
  • Do not exceed 8 doses (16 tablets) in 24 hours 1

For Children Under 12 Years:

  • Consult a doctor before administration 1

Efficacy in Treating Gastrointestinal Symptoms

  • Bismuth subsalicylate has been shown to reduce the number of stools passed and favorably alter subjective symptoms in patients with traveler's diarrhea 2
  • The medication has demonstrated beneficial effects in treating acute diarrhea with a modest therapeutic effect 3
  • In comparative studies, loperamide has shown faster and more effective relief of acute diarrhea symptoms than bismuth subsalicylate, though both treatments were well tolerated 4

Mechanism of Action and Absorption

  • In the gastrointestinal tract, bismuth subsalicylate is converted to salicylic acid and insoluble bismuth salts 5
  • The salicylate portion is extensively absorbed (greater than 90%) and excreted in urine 5
  • Very little bismuth is absorbed from the gastrointestinal tract (less than 0.005%), making it safe for short-term use 5, 6
  • The salicylate component exerts antisecretory effects in patients with diarrhea, while the bismuth and intestinal hydrolysis products have direct antimicrobial effects 2

Safety Considerations

  • Pepto-Bismol can be used safely for its acute indications and for up to 3-4 weeks of extended dosing 5
  • The maximal daily dose of Pepto-Bismol (4.2 g of bismuth subsalicylate) results in peak concentrations of salicylate in plasma considerably below the level of salicylate toxicity 5
  • Despite rapid and substantial absorption of salicylate, there is negligible absorption of bismuth into the bloodstream from standard oral doses 6

Alternative Treatment Options

  • For persistent or severe diarrhea, loperamide may be considered as it has been shown to be more effective than bismuth subsalicylate in some studies 4, 7
  • For mild travelers' diarrhea, bismuth subsalicylate may be considered as an alternative to loperamide 7
  • For gastrointestinal symptoms related to H. pylori infection, bismuth subsalicylate may be used as part of quadruple therapy along with antibiotics and a proton pump inhibitor 7, 8

Remember to follow the recommended dosage guidelines and not exceed the maximum daily dose. If symptoms persist beyond 2 days, consult a healthcare professional.

References

Research

Bismuth subsalicylate in the treatment and prevention of diarrheal disease.

Drug intelligence & clinical pharmacy, 1987

Research

Bismuth subsalicylate: history, chemistry, and safety.

Reviews of infectious diseases, 1990

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Helicobacter pylori Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.